Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Archivum Immunologiae Et Therapiae Experimentalis|April 25, 2012
Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicineGilbert Verbeken, Jean-Paul Pirnay, Daniel De Vos, et al.Biomed Research International|May 29, 2014
Taking bacteriophage therapy seriously: a moral argumentGilbert Verbeken, Isabelle Huys, Jean-Paul Pirnay, et al.International Journal of Burns and Trauma|October 31, 2014
Experimental phage therapy of burn wound infection: difficult first stepsThomas Rose, Gilbert Verbeken, Daniel De Vos, et al.Plos One|July 28, 2017
Stability of bacteriophages in burn wound care productsMaia Merabishvili, Riet Monserez, Jonas van Belleghem, et al.Cell and Tissue Banking|September 21, 2013
Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systemsJean-Paul Pirnay, Alain Vanderkelen, Daniel De Vos, et al.Plos One|November 26, 2009
Pseudomonas aeruginosa population structure revisitedJean-Paul Pirnay, Florence Bilocq, Bruno Pot, et al.Cell and Tissue Banking|March 12, 2011
Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safetyPeter De Corte, Gunther Verween, Gilbert Verbeken, et al.Cell and Tissue Banking|April 21, 2011
Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14 day culturesJean-Paul Pirnay, Gunther Verween, Bruno Pascual, et al.Surgical Technology International|April 13, 2007
Compact extracorporeal circulation: reducing the surface of cardiopulmonary bypass to improve outcomesUmberto Borrelli, Nawwar Al-Attar, Marc Detroux, et al.Experimental Dermatology|July 23, 2014
Real-time three-dimensional imaging of epidermal splitting and removal by high-definition optical coherence tomographyMarc Boone, Jean Pierre Draye, Gunther Verween, et al.Pageof 4